Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...

Mass Innovation Nights Showcases New Products at UMass Lowell’s iHub LOWELL, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- On Thursday, April 11, 2019, Mass Innovation Nights, Massachusetts’ leading monthly new product showcase, will showcase ten new products at UMass...